Inflammaging as a prodrome to Alzheimer's disease

Journal of Neuroinflammation

Volumn 5, Issue , 2008, Pages

  Giunta, Brian ^a   Fernandez, Francisco ^a,b   Nikolic, William V ^b   Obregon, Demian ^b   Rrapo, Elona ^a   Town, Terrence ^c,d   Tan, Jun ^b  

^a UNIVERSITY OF SOUTH FLORIDA   (United States)

^b UNIVERSITY OF SOUTH FLORIDA   (United States)

^c CEDARS SINAI MEDICAL CENTER   (United States)

^d UNIVERSITY OF CALIFORNIA   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ALZHEIMER DISEASE VACCINE; AMYLOID BETA PROTEIN; AMYLOID BETA PROTEIN[1-42]; BIOLOGICAL MARKER; CYTOKINE; DIOSMIN; EPIGALLOCATECHIN GALLATE; FLAVONOID; FLURBIPROFEN; GAMMA INTERFERON; GLUCOCORTICOID; HYDROXYCHLOROQUINE; LUTEOLIN; N2 [2 (3,5 DIFLUOROPHENYL) 2 HYDROXYACETYL] N1 (6,7 DIHYDRO 5 METHYL 6 OXO 5H DIBENZ[B,D]AZEPIN 7 YL)ALANINAMIDE; NONSTEROID ANTIINFLAMMATORY AGENT; PLACEBO; POLYPHENOL DERIVATIVE; SILIBININ; TRIFUSAL; UNCLASSIFIED DRUG;

ADAPTIVE IMMUNITY; AGING; ALZHEIMER DISEASE; BLOOD CELL; CELLULAR IMMUNITY; CLINICAL FEATURE; CLINICAL TRIAL; DISEASE EXACERBATION; DISEASE MODEL; DRUG ACTIVITY; GENOTYPE; HELPER CELL; HUMAN; IMMUNE SYSTEM; IMMUNOMODULATION; INFLAMMATION; INNATE IMMUNITY; NONHUMAN; PHAGOCYTE; REVIEW; UMBILICAL CORD BLOOD; UNSPECIFIED SIDE EFFECT; UPREGULATION; VACCINATION; ANIMAL; FETUS BLOOD; IMMUNOLOGY; PATHOPHYSIOLOGY; PHYSIOLOGY;

AGING; ALZHEIMER DISEASE; AMYLOID BETA-PROTEIN; ANIMALS; ANTI-INFLAMMATORY AGENTS, NON-STEROIDAL; DISEASE MODELS, ANIMAL; FETAL BLOOD; FLAVONOIDS; HUMANS; IMMUNE SYSTEM; INFLAMMATION; VACCINATION;

EID: 58149499431     PISSN: None     EISSN: 17422094     Source Type: Journal    
DOI: 10.1186/1742-2094-5-51     Document Type: Review

References (229)

1. Franceschi C Capri M Monti D Giunta S Olivieri F Sevini F Panourgia MP Invidia L Celani L Scurti M Cevenini E Castellani GC Salvioli S Inflammaging and anti-inflammaging: A systemic perspective on aging and longevity emerged from studies in humans Mech Ageing Dev 2007, 128:92-105. 10.1016/j.mad.2006.11.016 17116321
2. Salvioli S Capri M Valensin S Tieri P Monti D Ottaviani E Franceschi C Inflamm-aging, cytokines and aging: State of the art, new hypotheses on the role of mitochondria and new perspectives from systems biology Curr Pharm Des 2006, 12:3161-3171. 10.2174/138161206777947470 16918441
3. De Martinis M Franceschi C Monti D Ginaldi L Inflamm-ageing and lifelong antigenic load as major determinants of ageing rate and longevity FEBS Lett 2005, 579:2035-2039. 10.1016/j.febslet.2005.02.055 15811314
4. Fagiolo U Cossarizza A Scala E Fanales-Belasio E Ortolani C Cozzi E Monti D Franceschi C Paganelli R Increased cytokine production in mononuclear cells of healthy elderly people Eur J Immunol 1993, 23:2375-2378. 10.1002/eji.1830230950 8370415
5. Franceschi C Monti D Sansoni P Cossarizza A The immunology of exceptional individuals: The lesson of centenarians Immunol Today 1995, 16:12-16. 10.1016/0167-5699(95)80064-6 7880382
6. Lio D Scola L Crivello A Colonna-Romano G Candore G Bonafé M Cavallone L Marchegiani F Olivieri F Franceschi C Caruso C Inflammation, genetics, and longevity: Further studies on the protective effects in men of IL-10-1082 promoter SNP and its interaction with TNF-alpha -308 promoter SNP J Med Genet 2003, 40:296-299. 1735442 12676903 10.1136/ jmg.40.4.296
7. Candore G Colonna-Romano G Balistreri CR Di Carlo D Grimaldi MP Listì F Nuzzo D Vasto S Lio D Caruso C Biology of longevity: Role of the innate immune system Rejuvenation Res 2006, 9:143-148. 10.1089/ rej.2006.9.143 16608411
8. Vasto S Candore G Balistreri CR Caruso M Colonna-Romano G Grimaldi MP Listi F Nuzzo D Lio D Caruso C Inflammatory networks in ageing, age-related diseases and longevity Mech Ageing Dev 2007, 128:83-91. 10.1016/j.mad.2006.11.015 17118425
9. Giunta S Is inflammaging an auto[innate]immunity subclinical syndrome? Immun Ageing 2006, 3:12. 1716179 17173699 10.1186/1742-4933-3-12
10. Bruunsgaard H Skinhoj P Qvist J Pedersen BK Elderly humans show prolonged in vivo inflammatory activity during pneumococcal infections J Infect Dis 1999, 180:551-554. 10.1086/314873 10395881
11. Bruunsgaard H Pedersen BK The senile immune system Ugeskr Laeger 1999, 16:4740-4743.
12. Bruunsgaard H Andersen-Ranberg K Jeune B Pedersen AN Skinhøj P Pedersen BK A high plasma concentration of TNF-alpha is associated with dementia in centenarians J Gerontol A Biol Sci Med Sci 1999, 54:M357-64. 10462168
13. Zanni F Vescovini R Biasini C Fagnoni F Zanlari L Telera A Di Pede P Passeri G Pedrazzoni M Passeri M Franceschi C Sansoni P Marked increase with age of type 1 cytokines within memory and effector/cytotoxic CD8+ T cells in humans: A contribution to understand the relationship between inflammation and immunosenescence Exp Gerontol 2003, 38:981-987. 10.1016/ S0531-5565(03)00160-8 12954485
14. Giacconi R Cipriano C Albanese F Boccoli G Saba V Olivieri F Franceschi C Mocchegiani E The -174G/C polymorphism of IL-6 is useful to screen old subjects at risk for atherosclerosis or to reach successful ageing Exp Gerontol 2004, 39:621-628. 10.1016/j.exger.2003.12.013 15050298
15. Wikby A Nilsson BO Forsey R Thompson J Strindhall J Löfgren S Ernerudh J Pawelec G Ferguson F Johansson B The immune risk phenotype is associated with IL-6 in the terminal decline stage: Findings from the swedish NONA immune longitudinal study of very late life functioning Mech Ageing Dev 2006, 127:695-704. 10.1016/j.mad.2006.04.003 16750842
16. Mannucci PM Mari D Merati G Peyvandi F Tagliabue L Sacchi E Taioli E Sansoni P Bertolini S Franceschi C Gene polymorphisms predicting high plasma levels of coagulation and fibrinolysis proteins. A study in centenarians Arterioscler Thromb Vasc Biol 1997, 17:755-759. 9108791
17. Mari D Mannucci PM Coppola R Bottasso B Bauer KA Rosenbergm R Hypercoagulability in centenarians: The paradox of successful aging Blood 1995, 85:3144-3149. 7756646
18. Coppola R Mari D Lattuada A Franceschi C Von willebrand factor in italian centenarians Haematologica 2003, 88:39-43. 12551825
19. Bonfigli AR Sirolla C Cenerelli S Marra M Boemi M Franceschi C Testa I Mari D Sacchi E Testa R Plasminogen activator inhibitor-1 plasma level increases with age in subjects with the 4G allele at position -675 in the promoter region Thromb Haemost 2004, 92:1164-1165. 15543351
20. Bonafe M Olivieri F Cavallone L Giovagnetti S Mayegiani F Cardelli M Pieri C Marra M Antonicelli R Lisa R Rizzo MR Paolisso G Monti D Franceschi C A gender-dependent genetic predisposition to produce high levels of IL-6 is detrimental for longevity Eur J Immunol 2001, 31:2357-2361. 10.1002/ 1521-4141(200108)31:8<2357::AID-IMMU2357>3.0.CO;2-X 11500818
21. Cipriano C Caruso C Lio D Giacconi R Malavolta M Muti E Gasparini M Franceschi C Mocchegiani E The -308G/A polymorphism of TNF-alpha influences immunological parameters in old subjects affected by infectious diseases Int J Immunogenet 2005, 32:13-18. 10.1111/ j.1744-313X.2005.00490.x 15686588
22. Franceschi C Bonafe M Valensin S Olivieri F De Luca M De Benedictis G Inflamm-aging. an evolutionary perspective on immunosenescence Ann N Y Acad Sci 2000, 908:244-254. 10911963
23. Aspinall R Andrew D Immunosenescence: Potential causes and strategies for reversal Biochem Soc Trans 2000, 28:250-254. 10816137
24. Aspinall R Longevity and the immune response Biogerontology 2000, 1:273-278. 10.1023/A:1010046532657 11707904
25. Linton PJ Li SP Zhang Y Bautista B Huynh Q Trinh T Linton PJ Intrinsic versus environmental influences on T-cell responses in aging Immunol Rev 2005, 205:207-219. 10.1111/j.0105-2896.2005.00266.x 15882355
26. Allman D Miller JP B cell development and receptor diversity during aging Curr Opin Immunol 2005, 17:463-467. 16054808
27. Effros RB Dagarag M Spaulding C Man J The role of CD8+ T-cell replicative senescence in human aging Immunol Rev 2005, 205:147-157. 10.1111/j.0105-2896.2005.00259.x 15882351
28. Pawelec G When T cells get old Sci Aging Knowledge Environ 2005 2005, 50:pE39. 10.1126/sageke.2005.50.pe39 16354906
29. Fann M Chiu WK Wood WH Levine BL Becker KG Weng NP Gene expression characteristics of CD28null memory phenotype CD8+ T cells and its implication in T-cell aging Immunol Rev 2005, 205:190-206. 10.1111/ j.0105-2896.2005.00262.x 15882354
30. Weng NP Aging of the immune system: How much can the adaptive immune system adapt? Immunity 2006, 24:495-499. 2266981 16713964 10.1016/ j.immuni.2006.05.001
31. Cossarizza A Ortolani C Paganelli R Barbieri D Monti D Sansoni P Fagiolo U Castellani G Bersani F Londei M Franceschi C CD45 isoforms expression on CD4+ and CD8+ T cells throughout life, from newborns to centenarians: Implications for T cell memory Mech Ageing Dev 1996, 86:173-195. 10.1016/ 0047-6374(95)01691-0 8733112
32. Solana R Pawelec G Tarazona R Aging and innate immunity Immunity 2006, 24:491-494. 10.1016/j.immuni.2006.05.003 16713963
33. Tarazona R DelaRosa O Alonso C Ostos B Espejo J Pena J Solana R Increased expression of NK cell markers on T lymphocytes in aging and chronic activation of the immune system reflects the accumulation of effector/senescent T cells Mech Ageing Dev 2000, 121:77-88. 10.1016/ S0047-6374(00)00199-8 11164462
34. Khan N Shariff N Cobbold M Bruton R Ainsworth JA Sinclair AJ Nayak L Moss PA Cytomegalovirus seropositivity drives the CD8 T cell repertoire toward greater clonality in healthy elderly individuals J Immunol 2002, 169:1984-1992. 12165524
35. Koch S Solana R Dela Rosa O Pawelec G Human cytomegalovirus infection and T cell immunosenescence: A mini review Mech Ageing Dev 2006, 127:538-543. 10.1016/j.mad.2006.01.011 16513159
36. Ouyang Q Wagner WM Voehringer D Wikby A Klatt T Walter S Muller CA Pircher H Pawelec G Age-associated accumulation of CMV-specific CD8+ T cells expressing the inhibitory killer cell lectin-like receptor G1 (KLRG1) Exp Gerontol 2003, 38:911-920. 10.1016/S0531-5565(03)00134-7 12915213
37. Vsecovini R Telera A Fagnoni FF Biasini C Medici MC Valcavi P di Pede P Lucchini G Zanlari L Passeri G Zanni F Chezzi C Franchesci C Sansoni P Different contribution of EBV and CMV infections in very long-term carriers to age-related alterations of CD8+ T cells Exp Gerontol 2004, 39:1233-1243. 10.1016/j.exger.2004.04.004 15288697
38. Ouyang Q Wanger WM Wikby A Walter S Aubert G Dodi AI Travers P Pawelec G Large numbers of dysfunctional CD8+ T lymphocytes bearing receptors for a single dominant CMV epitope in the very old J Clin Immunol 2003, 23:247-257. 10.1023/A:1024580531705 12959217
39. Franceschi C Valensin S Fagnoni F Barbi C Bonafe M Biomarkers of immunosenescence within an evolutionary perspective: The challenge of heterogeneity and the role of antigenic load Exp Gerontol 1999, 34:911-921. 10.1016/S0531-5565(99)00068-6 10673145
40. Goronzy JJ Weyand CM T cell development and receptor diversity during aging Curr Opin Immunol 2005, 17:468-475. 16098723
41. Swain S Clise-Dwyer K Haynes L Homeostasis and the age-associated defect of CD4 T cells Semin Immunol 2005, 17:370-377. 10.1016/ j.smim.2005.05.007 15964201
42. Kovaiou RD Weiskirchner I Keller M Pfister G Cioca DP Grubeck-Loebensten B Age-related differences in phenotype and function of CD4+ T cells are due to a phenotypic shift from naive to memory effector CD4+ T cells Int Immunol 2005, 17:1359-1366. 10.1093/intimm/dxh314 16141244
43. Haynes L Eaton SM Burns EM Randall TD Swain SL Newly generated CD4 T cells in aged animals do not exhibit age-related defects in response to antigen J Exp Med 2005, 201:845-851. 2213095 15781577 10.1084/ jem.20041933
44. Kang I Hong MS Nolasco H Park SH Dan JM Choi JY Craft Kang I Age-associated change in the frequency of memory CD4+ T cells impairs long term CD4+ T cell responses to influenza vaccine J Immunol 2004, 173:673-681. 15210831
45. Almanzar G Schwaiger S Jenewein B Keller M Herndler-Brandstetter D Wurzner R Schonitzer D Grubeck-Lobenstein B Long-term cytomegalovirus infection leads to significant changes in the composition of the CD8+ T-cell repertoire, which may be the basis for an imbalance in the cytokine production profile in elderly persons J Virol 2005, 79:3675-3683. 1075718 15731261 10.1128/JVI.79.6.3675-3683.2005
46. Azuma M Phillips JH Lanier LL CD28- T lymphocytes. antigenic and functional properties J Immunol 1993, 150:1147-1159. 8381831
47. Effros RB Dagarag M Spaulding C Man J The role of CD8+ T-cell replicative senescence in human aging Immunol Rev 2005, 205:147-157. 10.1111/j.0105-2896.2005.00259.x 15882351
48. Tarazona R DelaRosa O Alonso C Ostos B Espejo J Pena J Solana R Increased expression of NK cell markers on T lymphocytes in aging and chronic activation of the immune system reflects the accumulation of effector/senescent T cells Mech Ageing Dev 2000, 121:77-88. 10.1016/ S0047-6374(00)00199-8 11164462
49. Pawelec G Akbar A Caruso C Solana R Grubeck-Loebenstein B Wikby A Pawelec G Human immunosenescence: Is it infectious? Immunol Rev 2005, 205:257-268. 10.1111/j.0105-2896.2005.00271.x 15882359
50. Fann M Chiu WK Wood WH 3rd Levine BL Becker KG Weng NP Gene expression characteristics of CD28null memory phenotype CD8+ T cells and its implication in T-cell aging Immunol Rev 2005, 205:190-206. 10.1111/ j.0105-2896.2005.00262.x 15882354
51. Almanzar G Schwaiger S Jenewein B Keller M Herndler-Brandstetter D Wurzner R Schonitzer D Grubeck-Loebenstein B Long-term cytomegalovirus infection leads to significant changes in the composition of the CD8+ T-cell repertoire, which may be the basis for an imbalance in the cytokine production profile in elderly persons J Virol 2005, 79:3675-3683. 1075718 15731261 10.1128/JVI.79.6.3675-3683.2005
52. Ghia P Melchers F Rolink AG Age-dependent changes in B lymphocyte development in man and mouse Exp Gerontol 2000, 35:159-165. 10.1016/ S0531-5565(99)00095-9 10767576
53. Szabo P Shen S Weksler ME Age-associated defects in B lymphocyte development Exp Gerontol 1999, 34:431-434. 10.1016/S0531-5565(99)00023-6 10433397
54. Weksler ME Changes in the B-cell repertoire with age Vaccine 2000, 18:1624-1628. 10.1016/S0264-410X(99)00497-1 10689139
55. Yang X Stedra J Cerny J Relative contribution of T and B cells to hypermutation and selection of the antibody repertoire in germinal centers of aged mice J Exp Med 1996, 183:959-970. 2192365 8642299 10.1084/jem.183.3.959
56. Zheng B Han S Takahashi Y Kelsoe G Immunosenescence and germinal center reaction Immunol Rev 1997, 160:63-77. 10.1111/j.1600-065X.1997.tb01028.x 9476666
57. Kraft R Bachmann M Bachmann K Buerki H Hess MW Cottier H Stoner RD Satisfactory primary tetanus antitoxin responses but markedly reduced germinal centre formation in first draining lymph nodes of ageing mice Clin Exp Immunol 1987, 67:447-453. 1542585 3608229
58. Franceschi C Cossarizza A Introduction: The reshaping of the immune system with age Int Rev Immunol 1995, 12:1-4. 10.3109/08830189509056697 7595010
59. Frasca D Riley RL Blomberg BB Humoral immune response and B-cell functions including immunoglobulin class switch are downregulated in aged mice and humans Semin Immunol 2005, 17:378-384. 10.1016/ j.smim.2005.05.005 15996480
60. Uyemura K Castle SC Makinodan T The frail elderly: Role of dendritic cells in the susceptibility of infection Mech Ageing Dev 2002, 123:955-962. 10.1016/S0047-6374(02)00033-7 12044944
61. Perlmutter LS Scott SA Barron E Chui HC MHC class II-positive microglia in human brain: Association with alzheimer lesions J Neurosci Res 1992, 33:549-558. 10.1002/jnr.490330407 1484388
62. O'Brien K Fitzgerald DC Naiken K Alugupalli KR Rostami AM Gran B Role of the innate immune system in autoimmune inflammatory demyelination Curr Med Chem 2008, 15:1105-1115. 10.2174/092986708784221458 18473806
63. Brehin AC Mouries J Frenkiel MP Dadaglio G Despres P Lafon M Couderc T Dynamics of immune cell recruitment during west nile encephalitis and identification of a new CD19+B220-BST-2+ leukocyte population J Immunol 2008, 180:6760-6767. 18453596
64. Herrero C Marques L Lloberas J Celada A IFN-gamma-dependent transcription of MHC class II IA is impaired in macrophages from aged mice J Clin Invest 2001, 107:485-493. 199261 11181648 10.1172/JCI11696
65. Plowden J Renshaw-Hoelscher M Engleman C Katz J Sambhara S Innate immunity in aging: Impact on macrophage function Aging Cell 2004, 3:161-167. 10.1111/j.1474-9728.2004.00102.x 15268749
66. Cumberbatch M Dearman RJ Kimber I Influence of ageing on langerhans cell migration in mice: Identification of a putative deficiency of epidermal interleukin-1beta Immunology 2002, 105:466-477. 1782675 11985667 10.1046/ j.1365-2567.2002.01381.x
67. Tan J Town T Crawford F Mori T DelleDonne A Crescentini R Obregon D Flavell RA Mullan MJ Role of CD40 ligand in amyloidosis in transgenic alzheimer's mice Nat Neurosci 2002, 5:1288-1293. 10.1038/nn968 12402041
68. Medzhitov R Janeway C Jr Innate immunity N Engl J Med 2000, 343:338-344. 10.1056/NEJM200008033430506 10922424
69. Krieger M The other side of scavenger receptors: Pattern recognition for host defense Curr Opin Lipidol 1997, 8:275-280. 9335951
70. Muzio M Natoli G Saccani S Levrero M Mantovani A The human toll signaling pathway: Divergence of nuclear factor kappaB and JNK/SAPK activation upstream of tumor necrosis factor receptor-associated factor 6 (TRAF6) J Exp Med 1998, 187:2097-2101. 2212359 9625770 10.1084/ jem.187.12.2097
71. Guha M Mackman N LPS induction of gene expression in human monocytes Cell Signal 2001, 13:85-94. 10.1016/S0898-6568(00)00149-2 11257452
72. Fagiolo U Cossarizza A Scala E Fanales-Belasio E Ortolani C Cozzi E Monti D Franceschi C Paganelli R Increased cytokine production in mononuclear cells of healthy elderly people Eur J Immunol 1993, 23:2375-2378. 10.1002/eji.1830230950 8370415
73. Ershler WB Sun WH Binkley N Gravenstein S Volk MJ Kamoske G Klopp RG Roecker EB Daynes RA Weindruch R Interleukin-6 and aging: Blood levels and mononuclear cell production increase with advancing age and in vitro production is modifiable by dietary restriction Lymphokine Cytokine Res 1993, 12:225-230. 8218595
74. Clark JA Peterson TC Cytokine production and aging: Overproduction of IL-8 in elderly males in response to lipopolysaccharide Mech Ageing Dev 1994, 77:127-139. 10.1016/0047-6374(94)90020-5 7745991
75. O'Mahony L Holland J Jackson J Feighery C Hennessy TP Mealy K Quantitative intracellular cytokine measurement: Age-related changes in proinflammatory cytokine production Clin Exp Immunol 1998, 113:213-219. 1905038 9717970 10.1046/j.1365-2249.1998.00641.x
76. Roubenoff R Harris TB Abad LW Wilson PW Dallal GE Dinarello CA Monocyte cytokine production in an elderly population: Effect of age and inflammation J Gerontol A Biol Sci Med Sci 1998, 53:M20-6. 9467429
77. Sadeghi HM Schnelle JF Thoma JK Nishanian P Fahey JL Phenotypic and functional characteristics of circulating monocytes of elderly persons Exp Gerontol 1999, 34:959-970. 10.1016/S0531-5565(99)00065-0 10673149
78. Hasegawa Y Sawada M Ozaki N Inagaki T Suzumura A Increased soluble tumor necrosis factor receptor levels in the serum of elderly people Gerontology 2000, 46:185-188. 10.1159/000022157 10859456
79. Mariani E Meneghetti A Neri S Ravaglia G Forti P Cattini L Facchini A Chemokine production by natural killer cells from nonagenarians Eur J Immunol 2002, 32:1524-1529. 10.1002/ 1521-4141(200206)32:6<1524::AID-IMMU1524>3.0.CO;2-E 12115634
80. Hayek MG Mura C Wu D Beharka AA Han SN Paulson KE Hwang D Meydani SN Enhanced expression of inducible cyclooxygenase with age in murine macrophages J Immunol 1997, 159:2445-2451. 9278337
81. Saurwein-Teissl M Lung TL Marx F Gschosser C Asch E Blasko I Parson W Bock G Schonitzer D Trannoy E Grubeck-Loebenstein B Lack of antibody production following immunization in old age: Association with CD8(+)CD28(-) T cell clonal expansions and an imbalance in the production of Th1 and Th2 cytokines J Immunol 2002, 168:5893-5899. 12023394
82. Bandres E Merino J Vazquez B Inoges S Moreno C Subira ML Sanchez-Ibarrola A The increase of IFN-gamma production through aging correlates with the expanded CD8(+high)CD28(-)CD57(+) subpopulation Clin Immunol 2000, 96:230-235. 10.1006/clim.2000.4894 10964541
83. Sakata-Kaneko S Wakatsuki Y Matsunaga Y Usui T Kita T Altered Th1/Th2 commitment in human CD4+ T cells with ageing Clin Exp Immunol 2000, 120:267-273. 1905644 10792375 10.1046/j.1365-2249.2000.01224.x
84. Karanfilov CI Liu B Fox CC Lakshmanan RR Whisler RL Age-related defects in Th1 and Th2 cytokine production by human T cells can be dissociated from altered frequencies of CD45RA+ and CD45RO+ T cell subsets Mech Ageing Dev 1999, 109:97-112. 10.1016/S0047-6374(99)00030-5 10515660
85. Mbawuike IN Acuna CL Walz KC Atmar RL Greenberg SB Couch RB Cytokines and impaired CD8+ CTL activity among elderly persons and the enhancing effect of IL-12 Mech Ageing Dev 1997, 94:25-39. 10.1016/ S0047-6374(96)01855-6 9147358
86. Rink L Cakman I Kirchner H Altered cytokine production in the elderly Mech Ageing Dev 1998, 102:199-209. 10.1016/S0047-6374(97)00153-X 9720652
87. Bernstein ED Gardner EM Abrutyn E Gross P Murasko DM Cytokine production after influenza vaccination in a healthy elderly population Vaccine 1998, 16:1722-1731. 10.1016/S0264-410X(98)00140-6 9778748
88. Gross PA Hermogenes AW Sacks HS Lau J Levandowski RA The efficacy of influenza vaccine in elderly persons. A meta-analysis and review of the literature Ann Intern Med 1995, 123:518-527. 7661497
89. Nichol KL Margolis KL Wuorenma J von Sternberg T The efficacy and cost effectiveness of vaccination against influenza among elderly persons living in the community N Engl J Med 1994, 331:778-784. 10.1056/ NEJM199409223311206 8065407
90. Saurwein-Teissl M Lung TL Marx F Gschosser C Asch E Blasko I Parson W Bock G Schonitzer D Trannoy E Grubeck-Loebenstein B Lack of antibody production following immunization in old age: Association with CD8(+)CD28(-) T cell clonal expansions and an imbalance in the production of Th1 and Th2 cytokines J Immunol 2002, 168:5893-5899. 12023394
91. McGeer PL McGeer EG Anti-inflammatory drugs in the fight against alzheimer's disease Ann N Y Acad Sci 1996, 777:213-220. 10.1111/ j.1749-6632.1996.tb34421.x 8624086
92. McGeer PL McGeer EG The inflammatory response system of brain: Implications for therapy of alzheimer and other neurodegenerative diseases Brain Res Brain Res Rev 1995, 21:195-218. 10.1016/ 0165-0173(95)00011-9 8866675
93. Shoenfeld Y Sherer Y Harats D Artherosclerosis as an infectious, inflammatory and autoimmune disease Trends Immunol 2001, 22:293-295. 10.1016/S1471-4906(01)01922-6 11419409
94. Nguyen TT Cho SO Ban JY Kim JY Ju HS Koh SB Song KS Seong YH Neuroprotective Effect of Sanguisorbae Radix against Oxidative Stress-Induced Brain Damage: In Vitro and in Vivo Biol Pharm Bull 2008, 31:2028-35. 10.1248/bpb.31.2028 18981568
95. Smith M Richey P Taneda S Kutty R Sayre L Monnier V Perry G Advanced Maillard reaction end products, free radicals, and protein oxidation in Alzheimer's disease Ann N Y Acad Sci 1994, 738:447-454. 7832455
96. Smith M Sayre L Monnier V Perry G Radical AGEing in Alzheimer's disease Trends Neurosci 1995, 18:172-176. 10.1016/0166-2236(95)93897-7 7778188
97. Smith M Rudnicka-Nawro M Richey P Praprotnik D Mulvihill P Miller C Sayre L Perry G Carbonyl-related posttranslational modification of neurofilament protein in the neurofibrillary pathology of Alzheimer's disease J Neurochem 1995, 64:2660-2666. 7539057
98. Smith M Perry G Richey P Sayre L Anderson V Beal M Kowall N Oxidative damage in Alzheimer's Nature 1996, 382:120-121. 10.1038/382120b0 8700201
99. Smith M Harris P Sayre L Perry G Iron accumulation in Alzheimer disease is a source of redox-generated free radicals Proc Natl Acad Sci 1997, 94:9866-9868. 23283 9275217 10.1073/pnas.94.18.9866
100. Smith M Richey Harris P Sayre L Beckman J Perry G Widespread peroxynitrite-mediated damage in Alzheimer's disease J Neurosci 1997. 17(8):2653-2657. 9092586
101. Cras M Kawai S Siedlak P Mulvihill P Gambetti D Lowery P Gonzalez-DeWhitt B Perry G Neuronal and microglial involvement in beta-amyloid protein deposition in Alzheimer's disease Am J Pathol 1990, 137:241-246. 1877622 2117395
102. Colton C Gilbert D Production of superoxide anions by a CNS macrophage, the microglia FEBS Lett 1987, 223:284-288. 10.1016/0014-5793(87)80305-8 2822487
103. Good P Werner P Hsu A Olanow C Perl D Evidence of neuronal oxidative damage in Alzheimer's disease Am J Pathol 1996, 149:21-28. 1865248 8686745
104. Akiyama H Barger S Barnum S Bradt B Bauer J Cole GM Cooper NR Eikelenboom P Emmerling M Fiebich BL Finch CE Frautschy S Griffin WS Hampel H Hull M Landreth G Lue L Mrak R Mackenzie IR McGeer PL O'Banion MK Pachter J Pasinetti G Plata-Salaman C Rogers J Rydel R Shen Y Streit W Strohmeyer R Tooyoma I Van Muiswinkel FL Veerhuis R Walker D Webster S Wegrzyniak B Wenk G Wyss-Coray T Inflammation and alzheimer's disease Neurobiol Aging 2000, 21:383-421. 10.1016/S0197-4580(00)00124-X 10858586
105. Nunomura A Perry G Aliev G Hirai K Takeda A Balraj EK Jones PK Ghanbari H Wataya T Shimohama S Chiba S Atwood CS Petersen RB Smith MA Oxidative damage is the earliest event in Alzheimer disease J Neuropathol Exp Neurol 2001, 60:759-67. 11487050
106. Richartz-Salzburger E Batra A Stransky E Laske C Kohler N Bartels M Buchkremer G Schott K Altered lymphocyte distribution in alzheimer's disease J Psychiatr Res 2007, 41:174-178. 10.1016/ j.jpsychires.2006.01.010 16516234
107. Smith M Hirai K Hsiao K Pappolla M Harris P Siedlak S Tabaton M Perry G Amyloid-beta deposition in Alzheimer transgenic mice is associated with oxidative stress J Neurochem 1998, 70:2212-2215. 9572310
108. Butterfield A Poon H St Clair D Keller J Pierce W Klein J Markesbery W Redox proteomics identification of oxidatively modified hippocampal proteins in mild cognitive impairment: Insights into the development of Alzheimer's disease Neurobiol Dis 2006, 22:223-232. 10.1016/ j.nbd.2005.11.002 16466929
109. Keller J Schmitt F Scheff S Ding Q Chen Q Butterfield D Markesbery W Evidence of increased oxidative damage in subjects with mild cognitive impairment Neurology 2005, 64:1152-1156. 15824339
110. Butterfield D Reed T Perluigi M De Marco C Coccia R Cini C Sultana R Elevated protein-bound levels of the lipid peroxidation product, 4-hydroxy-2-nonenal, in brain from persons with mild cognitive impairment Neurosci Lett 2006, 397:170-173. 10.1016/j.neulet.2005.12.017 16413966
111. Smith M Kutty R Richey P Yan S Stern D Chader G Wiggert B Petersen R Perry G Heme oxygenase-1 is associated with the neurofibrillary pathology of Alzheimer's disease Am J Pathol 1994, 145:42-47. 1887290 8030754
112. Lue LF Brachova L Civin WH Rogers J Inflammation, A beta deposition, and neurofibrillary tangle formation as correlates of alzheimer's disease neurodegeneration J Neuropathol Exp Neurol 1996, 55:1083-1088. 8858005
113. Webster S Lue LF Brachova L Tenner AJ McGeer PL Terai K Walker DG Bradt B Cooper NR Rogers J Molecular and cellular characterization of the membrane attack complex, C5b-9, in alzheimer's disease Neurobiol Aging 1997, 18:415-421. 10.1016/S0197-4580(97)00042-0 9330973
114. Blasko I Knaus G Weiss E Kemmler G Winkler C Falkensammer G Griesmacher A Wurzner R Marksteiner J Fuchs D Cognitive deterioration in alzheimer's disease is accompanied by increase of plasma neopterin J Psychiatr Res 2007, 41:694-701. 10.1016/j.jpsychires.2006.02.001 16542679
115. Mrak RE Griffin WS Glia and their cytokines in progression of neurodegeneration Neurobiol Aging 2005, 26;349-354. 10.1016/ j.neurobiolaging.2004.05.010 15639313
116. Blasko I Stampfer-Kountchev M Robatscher P Veerhuis R Eikelenboom P Grubeck-Loebenstein B How chronic inflammation can affect the brain and support the development of alzheimer's disease in old age: The role of microglia and astrocytes Aging Cell 2004, 3:169-176. 10.1111/ j.1474-9728.2004.00101.x 15268750
117. Franceschi C Bonafe M Centenarians as a model for healthy aging Biochem Soc Trans 2003, 31:457-461. 10.1042/BST0310457 12653662
118. Franceschi C Capri M Monti D Giunta S Olivieri F Sevini F Panourgia MP Invidia L Celani L Scurti M Cevenini E Castellani GC Salvioli S Inflammaging and anti-inflammaging: A systemic perspective on aging and longevity emerged from studies in humans Mech Ageing Dev 2007, 128:92-105. 10.1016/j.mad.2006.11.016 17116321
119. Mutus B Rabini RA Franceschi C Paolisso G Rizzo MR Ragno E Rappelli A Braconi M Mazzanti L Cellular resistance to homocysteine: A key for longevity Atherosclerosis 2000, 152:527-528. 10.1016/ S0021-9150(00)00546-3 11203425
120. Rabini RA Vignini A Martarelli D Nanetti L Salvolini E Rizzo MR Ragno E Paolisso G Franceschi C Mazzanti L Evidence for reduction of pro-atherosclerotic properties in platelets from healthy centenarians Exp Gerontol 2003, 38:367-371. 10.1016/S0531-5565(02)00268-1 12670623
121. Nanetti L Vignini A Moroni C Bartolini M Luzzi S Provinciali L Mazzanti L Peroxynitrite production and NOS expression in astrocytes U373MG incubated with lipoproteins from alzheimer patients Brain Res 2005, 1054:38-44. 10.1016/j.brainres.2005.06.025 16054114
122. Nanetti L Moroni C Vignini A Vannini P Franceschi C Mazzanti L Age-related changes on platelet membrane: A study on elderly and centenarian monozygotic twins Exp Gerontol 2005, 40:519-525. 10.1016/ j.exger.2005.07.002 15935592
123. Kario K Matsuo T Relation between sialic acid concentrations and the haemostatic system in the elderly BMJ 1993, 306:1650-1651. 1678041 8324435
124. Troiano L Pini G Petruzzi E Ognibene A Franceschi C Monti D Masotti G Cilotti A Forti G Evaluation of adrenal function in aging J Endocrinol Invest 1999, 22:74-75. 10727055
125. Lio D Scola L Crivello A Colonna-Romano G Candore G Bonafe M Cavallone L Franceschi C Caruso C Gender-specific association between -1082 IL-10 promoter polymorphism and longevity Genes Immun 2002, 3:30-33. 10.1038/ sj.gene.6363827 11857058
126. Lio D Licastro F Scola L Chiappelli M Grimaldi LM Crivello A Colonna-Romano G Candore G Franceschi C Caruso C Interleukin-10 promoter polymorphism in sporadic alzheimer's disease Genes Immun 2003, 4:234-238. 10.1038/sj.gene.6363964 12700599
127. Richartz-Salzburger E Batra A Stransky E Laske C Kohler N Bartels M Buchkremer G Schott K Altered lymphocyte distribution in alzheimer's disease J Psychiatr Res 2007, 41:174-178. 10.1016/ j.jpsychires.2006.01.010 16516234
128. Murr C Hainz U Asch E Berger P Jenewein B Saurwein-Teissl M Grubeck-Loebenstein B Fuchs D Association of increased neopterin production with decreased humoral immunity in the elderly Exp Gerontol 2003, 38:583-587. 10.1016/S0531-5565(03)00062-7 12742536
129. Wirleitner B Schroecksnadel K Winkler C Fuchs D Neopterin in HIV-1 infection Mol Immunol 2005, 42:183-194. 10.1016/j.molimm.2004.06.017 15488607
130. Blasko I Knaus G Weiss E Kemmler G Winkler C Falkensammer G Griesmacher A Wurzner R Marksteiner J Fuchs D Cognitive deterioration in alzheimer's disease is accompanied by increase of plasma neopterin J Psychiatr Res 2007, 41:694-701. 10.1016/j.jpsychires.2006.02.001 16542679
131. Leblhuber F Walli J Demel U Tilz GP Widner B Fuchs D Increased serum neopterin concentrations in patients with alzheimer's disease Clin Chem Lab Med 1999, 37:429-431. 10.1515/CCLM.1999.070 10369114
132. Hull M Pasinetti GM Aisen PS Elevated plasma neopterin levels in alzheimer disease Alzheimer Dis Assoc Disord 2000, 14:228-230. 10.1097/ 00002093-200010000-00007 11186601
133. Ikeda T Yamamoto K Takahashi K Yamada M Immune system-associated antigens on the surface of peripheral blood lymphocytes in patients with alzheimer's disease Acta Psychiatr Scand 1991, 83:444-448. 10.1111/ j.1600-0447.1991.tb05573.x 1679280
134. Singh VK Studies of neuroimmune markers in alzheimer's disease Mol Neurobiol 1994, 9:73-81. 10.1007/BF02816106 7534089
135. Skias D Bania M Reder AT Luchins D Antel JP Senile dementia of alzheimer's type (SDAT): Reduced T8+-cell-mediated suppressor activity Neurology 1985, 35:1635-1638. 2932656
136. Singh VK Fudenberg HH Brown FR 3rd Immunologic dysfunction: Simultaneous study of alzheimer's and older down's patients Mech Ageing Dev 1986 37 257 264 10.1016/0047-6374(86)90043-6 2952844
137. Leffell MS Lumsden L Steiger WA An analysis of T lymphocyte subpopulations in patients with alzheimer's disease J Am Geriatr Soc 1985, 33:4-8. 3155531
138. Shalit F Sredni B Brodie C Kott E Huberman M T lymphocyte subpopulations and activation markers correlate with severity of alzheimer's disease Clin Immunol Immunopathol 1995, 75:246-250. 10.1006/clin.1995.1078 7768042
139. Trieb K Ransmayr G Sgonc R Lassmann H Grubeck-Loebenstein B APP peptides stimulate lymphocyte proliferation in normals, but not in patients with alzheimer's disease Neurobiol Aging 1996, 17:541-547. 10.1016/ 0197-4580(96)00068-1 8832628
140. Singh VK Studies of neuroimmune markers in alzheimer's disease Mol Neurobiol 1994, 9:73-81. 10.1007/BF02816106 7534089
141. Xu J Hong Y Shen W Wang L Di Q Zhang Y Sun Y Xu W Hu X P1-369: The impaired suppression function of peripheral blood CD4+ CD25hi regulatory T cells in patients with Alzheimer's disease Alz and dementia 2008, 4:T327. 10.1016/j.jalz.2008.05.951
142. Schindowski K Peters J Gorriz C Schramm U Weinandi T Leutner S Maurer K Frolich L Muller WE Eckert A Apoptosis of CD4+ T and natural killer cells in alzheimer's disease Pharmacopsychiatry 2006, 39:220-228. 10.1055/s-2006-954591 17124644
143. Sastre M Dewachter I Landreth GE Willson TM Klockgether T van Leuven F Heneka MT Nonsteroidal anti-inflammatory drugs and peroxisome proliferator-activated receptor-gamma agonists modulate immunostimulated processing of amyloid precursor protein through regulation of beta-secretase J Neurosci 2003, 23:9796-9804. 14586007
144. Blasko I Marx F Steiner E Hartmann T Grubeck-Loebenstein B TNFalpha plus IFNgamma induce the production of alzheimer beta-amyloid peptides and decrease the secretion of APPs FASEB J 1999, 13:63-68. 9872930
145. Mackic JB Bading J Ghiso J Walker L Wisniewski T Frangione B Zlokovic BV Circulating amyloid-beta peptide crosses the blood-brain barrier in aged monkeys and contributes to alzheimer's disease lesions Vascul Pharmacol 2002, 38:303-313. 10.1016/S1537-1891(02)00198-2 12529925
146. Zlokovic BV Deane R Sallstrom J Chow N Miano JM Neurovascular pathways and alzheimer amyloid beta-peptide Brain Pathol 2005, 15:78-83. 15779240
147. Zhu X Lee HG Perry G Smith MA Alzheimer disease, the two-hit hypothesis: an update Biochim Biophys Acta 2007, 1772:494-502. 17142016
148. Nagy Z Esiri M Smith A Expression of cell division markers in the hippocampus in Alzheimer's disease and other neurodegenerative conditions Acta Neuropathol (Berl) 1997, 93:294-300. 10.1007/ s004010050617
149. McShea A Harris P Webster K Wahl A Smith M Abnormal expression of the cell cycle regulators P16 and CDK4 in Alzheimer's disease Am J Pathol 1997, 150:1933-1939. 1858317 9176387
150. Vincent J Zheng D Dickson D Kress Y Davies P Mitotic phosphoepitopes precede paired helical filaments in Alzheimer's disease Neurobiol Aging 1998, 19:287-296. 10.1016/S0197-4580(98)00071-2 9733160
151. Yang Y Mufson E Herrup K Neuronal cell death is preceded by cell cycle events at all stages of Alzheimer's disease J Neurosci 2003, 23:2557-2563. 12684440
152. McGeer PL Schulzer M McGeer EG Arthritis and anti-inflammatory agents as possible protective factors for Alzheimer's disease: A review of 17 epidemiologic studies Neurology 1996, 47:425-432. 8757015
153. Breitner JC Gau BA Welsh KA Inverse association of anti-inflammatory treatments and Alzheimer's disease: Initial results of a co-twin control study Neurology 1994, 44:227-232. 8309563
154. Breitner JCS Welsh KA Helms MJ Delayed onset of Alzheimer's disease with nonsteroidal anti-inflammatory and histamine H2 blocking drugs Neurobiol Aging 1995 16 523 530 10.1016/0197-4580(95)00049-K 8544901
155. Rogers J Kirby LC Hempelman SR Clinical trial of indomethacin in Alzheimer's disease Neurology 1993, 43:1609-1611. 8351023
156. Scharf S Mander A Ugoni A A double-blind, placebo-controlled trial of diclofenac/misoprostol in Alzheimer's disease Neurology 1999, 53:197-201. 10408559
157. Aisen PS Davis KL Berg JD A randomized controlled trial of prednisone in Alzheimer's disease. Alzheimer's Disease Cooperative Study Neurology 2000, 54:588-593. 10680787
158. Aisen PS Schafer KA Grundman M Effects of rofecoxib or naproxen versus placebo on Alzheimer disease progression: A randomized controlled trial JAMA 2003 289 2819 2826 10.1001/jama.289.21.2819 12783912
159. Thal LJ Ferris SH Kirby L A randomized, double-blind, study of rofecoxib in patients with mild cognitive impairment Neuropsychopharmacology 2005, 30:1204-1215. 10.1038/sj.npp.1300690 15742005
160. Group AR Lyketsos CG Breitner JC Naproxen and celecoxib do not prevent AD in early results from a randomized controlled trial Neurology 2007, 68:1800-1808. 10.1212/01.wnl.0000260269.93245.d2 17460158
161. van Gool WA Weinstein HC Scheltens PK Effect of hydroxychloroquine on progression of dementia in early Alzheimer's disease: An 18-month randomised, double-blind, placebo- controlled study Lancet 2001, 358:455-460. 10.1016/S0140-6736(01)05623-9 11513909
162. Siemers E Skinner M Dean R Gonzales C Satterwhite J Farlow M Ness D May P Safety, tolerability, and changes in amyloid beta concentrations after administration of a gamma-secretase inhibitor in volunteers Clin Neuropharmacol 2005, 28:126-132. 10.1097/01.wnf.0000167360.27670.29 15965311
163. Siemers E Quinn J Kaye J Farlow M Porsteinsson A Tariot P Zoulnouni P Galvin J Holtzman D Knopman D Satterwhite J Gonzales C Dean R May P Effects of a gamma-secretase inhibitor in a randomized study of patients with alzheimers disease Neurology 2006, 66:602-604. 10.1212/ 01.WNL.0000198762.41312.E1 16505324
164. Geerts H Drug evaluation: (R)-flurbiprofen-an enantiomer of flurbiprofen for the treatment of alzheimer's disease IDrugs 2007, 10:121-133. 17285465
165. Gómez-Isla T Blesa R Boada M Clarimon J Del Ser T Domenech G Ferro J Gomez-Anson B Manubens J Martinez-Lage J Munoz D Pena-Casanova J Torres F A randomized, double-blind, placebo controlled-trial of triflusal in mild cognitive impairment: The TRIMCI study Alzheimer Dis Assoc Disord 2008, 22:21-29. 18317243
166. Schenk D Barbour R Dunn W Gordon G Grajeda H Guido T Hu K Huang J Johnson-Wood K Khan K Kholodenko D Lee M Liao Z Lieberburg I Motter R Mutter L Soriano F Shopp G Vasquez N Vandevert C Walker S Wogulis M Yednock T Games D Seubert P Immunization with amyloid-beta attenuates alzheimer-disease-like pathology in the PDAPP mouse Nature 1999, 400:173-177. 10.1038/22124 10408445
167. Bard F Cannon C Barbour R Burke RL Games D Grajeda H Guido T Hu K Huang J Johnson-Wood K Khan K Kholodenko D Lee M Lieberburg I Motter R Nguyen M Soriano F Vasquez N Weiss K Welch B Seubert P Schenk D Yednock T Peripherally administered antibodies against amyloid beta-peptide enter the central nervous system and reduce pathology in a mouse model of Alzheimer disease Nature medicine 2000, 6:916-919. 10.1038/78682 10932230
168. Holmes C Boche D Wilkinson D Yadegarfar G Hopkins V Bayer A Jones RW Bullock R Love S Neal JW Zotova E Nicoll JA Long-term effects of Abeta42 immunisation in Alzheimer's disease: Follow-up of a randomised, placebo-controlled phase I trial Lancet 2008, 372:216-23. 10.1016/ S0140-6736(08)61075-2 18640458
169. Koller MF Mohajeri MH Huber M Wollmer MA Roth Z'graggen BV Sandmeier E Moritz E Tracy J Nitsch RM Christen P Active immunization of mice with an abeta-Hsp70 vaccine Neurodegener Dis 2004, 1:20-28. 10.1159/000076666 16908970
170. Frenkel D Dewachter I van Leuven F Solomon B Reduction of beta-amyloid plaques in brain of transgenic mouse model of alzheimer's disease by EFRH-phage immunization Vaccine 2003, 21:1060-1065. 10.1016/ S0264-410X(02)00609-6 12559780
171. Hara H Monsonego A Yuasa K Adachi K Xiao X Takeda S Takahashi K Weiner HL Tabira T Development of a safe oral abeta vaccine using recombinant adeno-associated virus vector for alzheimer's disease J Alzheimers Dis 2004, 6:483-488. 15505369
172. Zhang J Wu X Qin C Qi J Ma S Zhang H Kong Q Chen D Ba D He W A novel recombinant adeno-associated virus vaccine reduces behavioral impairment and beta-amyloid plaques in a mouse model of alzheimer's disease Neurobiol Dis 2003, 14:365-379. 10.1016/j.nbd.2003.07.005 14678754
173. Furlan R Brambilla E Sanvito F Roccatagliata L Olivieri S Bergami A Pluchino S Uccelli A Comi G Martino G Vaccination with amyloid-beta peptide induces autoimmune encephalomyelitis in C57/BL6 mice Brain 2003, 126:285-291. 10.1093/brain/awg031 12538398
174. Nikolic WV Bai Y Obregon D Hou H Mori T Zeng J Ehrhart J Shytle RD Giunta B Morgan D Town T Tan J Transcutaneous beta-amyloid immunization reduces cerebral beta-amyloid deposits without T cell infiltration and microhemorrhage Proc Natl Acad Sci USA 2007, 104:2507-2512. 1892920 17264212 10.1073/pnas.0609377104
175. Town T Vendrame M Patel A Poetter D DelleDonne A Mori T Smeed R Crawford F Klein T Tan J Mullan M Reduced Th1 and enhanced Th2 immunity after immunization with Alzheimer's beta-amyloid(1-42). Reduced Th1 and enhanced Th2 immunity J Neuroimmunol 2002, 132:49-59. 10.1016/ S0165-5728(02)00307-7 12417433
176. Town T Tan J Sansone N Obregon D Klein T Mullan M Characterization of murine immunoglobulin G antibodies against human amyloid-beta1-42 Neurosci Lett 2002, 307:101-104. 10.1016/S0304-3940(01)01951-6
177. DeMattos RB Bales KR Cummins DJ Paul SM Holtzman DM Brain to plasma amyloid-beta efflux: A measure of brain amyloid burden in a mouse model of Alzheimer's disease Science 2002, 295:2264-2267. 10.1126/ science.1067568 11910111
178. Vendrame M Anti-inflammatory effects of human cord blood cells in a rat model of stroke Stem Cells Dev 2005, 14:595-604. 10.1089/scd.2005.14.595 16305344
179. Vendrame M Cassady J Newcomb J Butler T Pennypacker KR Zigova T Sanberg CD Sanberg PR Willing AE Infusion of human umbilical cord blood cells in a rat model of stroke dose-dependently rescues behavioral deficits and reduces infarct volume Stroke 2004, 35:2390-2395. 10.1161/ 01.STR.0000141681.06735.9b 15322304
180. El-Badri NS Hakki A Saporta S Liang X Madhusodanan S Willing AE Sanberg CD Sanberg PR Cord blood mesenchymal stem cells: Potential use in neurological disorders Stem Cells Dev 2006, 15:497-506. 10.1089/ scd.2006.15.497 16978054
181. Garbuzova-Davis S Gografe SJ Sanberg CD Willing AE Saporta S Cameron DF Desjarlais T Daily J Kuzmin-Nichols N Chamizo W Klasko SK Sanberg PR Maternal transplantation of human umbilical cord blood cells provides prenatal therapy in sanfilippo type B mouse model FASEB J 2006, 20:485-487. 16401642
182. Henning SM Aronson W Niu Y Conde F Lee NH Seeram NP Lee RP Lu J Harris DM Moro A Hong J Pak-Shan L Barnard RJ Ziaee HG Csathy G Go VL Wang H Heber D Tea polyphenols and theaflavins are present in prostate tissue of humans and mice after green and black tea consumption J Nutr 2006, 136:1839-1843. 16772446
183. Nikolic WV Hou H Town T Zhu Y Giunta B Sanberg CD Zeng J Luo D Ehrhart J Mori T Sanberg PR Tan J Peripherally administered human umbilical cord blood cells reduce parenchymal and vascular beta-amyloid deposits in alzheimer mice Stem Cells Dev 2008, 18366296,
184. Tan J Town T Paris D Placzek A Parker T Crawford F Yu H Humphrey J Mullan M Activation of microglial cells by the CD40 pathway: Relevance to multiple sclerosis J Neuroimmunol 1999, 97:77-85. 10.1016/ S0165-5728(99)00053-3 10408982
185. Tan J Town T Saxe M Paris D Wu Y Mullan M Ligation of microglial CD40 results in p44/42 mitogen-activated protein kinase-dependent TNF-alpha production that is opposed by TGF-beta 1 and IL-10 J Immunol 1999, 163:6614-6621. 10586056
186. Tan J Town T Paris D Mori T Suo Z Crawford F Mattson MP Flavell RA Mullan M Microglial activation resulting from CD40-CD40L interaction after beta-amyloid stimulation Science 1999, 286:2352-2355. 10.1126/ science.286.5448.2352 10600748
187. Nguyen VT Walker WS Benveniste EN Post-transcriptional inhibition of CD40 gene expression in microglia by transforming growth factor-beta Eur J Immunol 1998, 28:2537-2548. 10.1002/ (SICI)1521-4141(199808)28:08<2537::AID-IMMU2537>3.0.CO;2-1 9710231
188. Carson MJ Reilly CR Sutcliffe JG Lo D Mature microglia resemble immature antigen-presenting cells Glia 1998, 22:72-85. 10.1002/ (SICI)1098-1136(199801)22:1<72::AID-GLIA7>3.0.CO;2-A 9436789
189. Gerritse K Laman JD Noelle RJ Aruffo A Ledbetter JA Boersma WJ Claassen E CD40-CD40 ligand interactions in experimental allergic encephalomyelitis and multiple sclerosis Proc Natl Acad Sci USA 1996, 93:2499-2504. 39826 8637903 10.1073/pnas.93.6.2499
190. Desideri G Cipollone F Necozione S Marini C Lechiara MC Taglieri G Zuliani G Fellin R Mezzetti A di Orio F Ferri C Enhanced soluble CD40 ligand and alzheimer's disease: Evidence of a possible pathogenetic role Neurobiol Aging 2008, 29:348-356. 10.1016/j.neurobiolaging.2006.10.019 17123665
191. Marambaud P Zhao H Davies P Resveratrol promotes clearance of alzheimer's disease amyloid-beta peptides J Biol Chem 2005, 280:37377-37382. 10.1074/jbc.M508246200 16162502
192. Rezai-Zadeh K Shytle D Sun N Mori T Hou H Jeanniton D Ehrhart J Townsend K Zeng J Morgan D Hardy J Town T Tan J Green tea epigallocatechin-3-gallate (EGCG) modulates amyloid precursor protein cleavage and reduces cerebral amyloidosis in alzheimer transgenic mice J Neurosci 2005, 25:8807-8814. 10.1523/JNEUROSCI.1521-05.2005 16177050
193. Obregon DF Rezai-Zadeh K Bai Y Sun N Hou H Ehrhart J Zeng J Mori T Arendash GW Shytle D Town T Tan J ADAM10 activation is required for green tea (-)-epigallocatechin-3-gallate-induced alpha-secretase cleavage of amyloid precursor protein J Biol Chem 2006, 281:16419-16427. 10.1074/jbc.M600617200 16624814
194. Giunta B Obregon D Hou H Zeng J Sun N Nikolic V Ehrhart J Shytle D Fernandez F Tan J EGCG mitigates neurotoxicity mediated by HIV-1 proteins gp120 and tat in the presence of IFN-gamma: Role of JAK/STAT1 signaling and implications for HIV-associated dementia Brain Res 2006, 1123:216-225. 10.1016/j.brainres.2006.09.057 17078933
195. Yang F Lim GP Begum AN Ubeda OJ Simmons MR Ambegaokar SS Chen PP Kayed R Glabe CG Frautschy SA Cole GM Curcumin inhibits formation of amyloid beta oligomers and fibrils, binds plaques, and reduces amyloid in vivo J Biol Chem 2005, 280:5892-5901. 10.1074/jbc.M404751200 15590663
196. Beecher GR Overview of dietary flavonoids: Nomenclature, occurrence and intake J Nutr 2003, 133:3248S-3254S. 14519822
197. Hashimoto F Ono M Masuoka C Ito Y Sakata Y Shimizu K Nonaka G Nishioka I Nohara T Evaluation of the anti-oxidative effect (in vitro) of tea polyphenols Biosci Biotechnol Biochem 2003, 67:396-401. 10.1271/ bbb.67.396 12729007
198. Bors W Saran M Radical scavenging by flavonoid antioxidants Free Radic Res Commun 1987, 2:289-294. 10.3109/10715768709065294 3504810
199. Zheng LT Ock J Kwon BM Suk K Suppressive effects of flavonoid fisetin on lipopolysaccharide-induced microglial activation and neurotoxicity Int Immunopharmacol 2008, 8:484-494. 10.1016/j.intimp.2007.12.012 18279803
200. Zheng LT Ock J Kwon BM Suk K Suppressive effects of flavonoid fisetin on lipopolysaccharide-induced microglial activation and neurotoxicity Int Immunopharmacol 2008, 8:484-494. 10.1016/j.intimp.2007.12.012 18279803
201. Kim JS Jobin C The flavonoid luteolin prevents lipopolysaccharide-induced NF-kappaB signalling and gene expression by blocking IkappaB kinase activity in intestinal epithelial cells and bone-marrow derived dendritic cells Immunology 2005, 115:375-387. 1782165 15946255 10.1111/j.1365-2567.2005.02156.x
202. Kim JY Kina T Iwanaga Y Noguchi H Matsumura K Hyon SH Tea polyphenol inhibits allostimulation in mixed lymphocyte culture Cell Transplant 2007, 16:75-83. 10.3727/000000007783472381 17436857
203. Mantena SK Roy AM Katiyar SK Epigallocatechin-3-gallate inhibits photocarcinogenesis through inhibition of angiogenic factors and activation of CD8+ T cells in tumors Photochem Photobiol 2005, 81:1174-1179. 10.1562/2005-04-11-RA-487 15938647
204. Kang TH Lee JH Song CK Han HD Shin BC Pai SI Hung CF Trimble C Lim JS Kim TW Wu TC Epigallocatechin-3-gallate enhances CD8+ T cell-mediated antitumor immunity induced by DNA vaccination Cancer Res 2007, 67:802-811. 10.1158/0008-5472.CAN-06-2638 17234792
205. Min K Yoon WK Kim SK Kim BH Immunosuppressive effect of silibinin in experimental autoimmune encephalomyelitis Arch Pharm Res 2007, 30:1265-1272. 10.1007/BF02977779 18038905
206. Watson JL Ansari S Cameron H Wang A Akhtar M McKay DM Green tea polyphenol (-)-epigallocatechin gallate blocks epithelial barrier dysfunction provoked by IFN-gamma but not by IL-4 Am J Physiol Gastrointest Liver Physiol 2004, 287:G954-961. 10.1152/ajpgi.00302.2003 15231486
207. Ahn HY Xu Y Davidge ST Epigallocatechin-3-O-gallate inhibits TNFalpha-induced monocyte chemotactic protein-1 production from vascular endothelial cells Life Sci 2008, 82:964-968. 10.1016/j.lfs.2008.02.018 18397796
208. Xu Z Chen S Li X Luo G Li L Le W Neuroprotective effects of (-)-epigallocatechin-3-gallate in a transgenic mouse model of amyotrophic lateral sclerosis Neurochem Res 2006, 31:1263-1269. 10.1007/ s11064-006-9166-z 17021948
209. Graff JC Jutila MA Differential regulation of CD11b on gammadelta T cells and monocytes in response to unripe apple polyphenols J Leukoc Biol 2007, 82:603-607. 10.1189/jlb.0207125 17540733
210. Yoneyama S Kawai K Tsuno NH Okaji Y Asakage M Tsuchiya T Yamada J Sunami E Osada T Kitayama J Takahashi K Nagawa H Epigallocatechin gallate affects human dendritic cell differentiation and maturation J Allergy Clin Immunol 2008, 121:209-214. 10.1016/j.jaci.2007.08.026 17935769
211. Hsiao K Chapman P Nilsen S Eckman C Harigaya Y Younkin S Yang F Cole G Correlative memory deficits, abeta elevation, and amyloid plaques in transgenic mice Science 1996, 274:99-102. 10.1126/science.274.5284.99 8810256
212. Rezai-Zadeh K Shytle RD Bai Y Tian J Hou H Mori T Zeng J Obregon D Town T Tan J Flavonoid-mediated presenilin-1 phosphorylation reduces alzheimer's disease beta-amyloid production J Cell Mol Med 2008, 18410522
213. Hyun SK Jung HA Chung HY Choi JS In vitro peroxynitrite scavenging activity of 6-hydroxykynurenic acid and other flavonoids from gingko biloba yellow leaves Arch Pharm Res 2006, 29:1074-1079. 10.1007/ BF02969294 17225453
214. Horvathova K Novotny L Tothova D Vachalkova A Determination of free radical scavenging activity of quercetin, rutin, luteolin and apigenin in H2O2-treated human ML cells K562 Neoplasma 2004, 51:395-399. 15640946
215. Hougee S Sanders A Faber J Graus YM Berg van den WB Garssen J Smit HF Hoijer MA Decreased pro-inflammatory cytokine production by LPS-stimulated PBMC upon in vitro incubation with the flavonoids apigenin, luteolin or chrysin, due to selective elimination of monocytes/ macrophages Biochem Pharmacol 2005, 69:241-248. 10.1016/ j.bcp.2004.10.002 15627476
216. Verbeek R Plomp AC van Tol EA van Noort JM The flavones luteolin and apigenin inhibit in vitro antigen-specific proliferation and interferon-gamma production by murine and human autoimmune T cells Biochem Pharmacol 2004, 68:621-629. 10.1016/j.bcp.2004.05.012 15276069
217. Hirano T Higa S Arimitsu J Naka T Ogata A Shima Y Fujimoto M Yamadori T Ohkawara T Kuwabara Y Kawai M Matsuda H Yoshikawa M Maezaki N Tanaka T Kawase I Tanaka T Luteolin, a flavonoid, inhibits AP-1 activation by basophils Biochem Biophys Res Commun 2006. 340:1-7. 16343431
218. Hirano T Higa S Arimitsu J Naka T Shima Y Ohshima S Fujimoto M Yamadori T Kawase I Tanaka T Flavonoids such as luteolin, fisetin and apigenin are inhibitors of interleukin-4 and interleukin-13 production by activated human basophils Int Arch Allergy Immunol 2004, 134:135-140. 10.1159/000078498 15153793
219. Hirata Y Masuda Y Kakutani H Higuchi T Takada K Ito A Nakagawa Y Ishii H Sp1 is an essential transcription factor for LPS-induced tissue factor expression in THP-1 monocytic cells, and nobiletin represses the expression through inhibition of NF-kappaB, AP-1, and Sp1 activation Biochem Pharmacol 2008, 75:1504-1514. 10.1016/j.bcp.2007.12.019 18261712
220. Zheng LT Ock J Kwon BM Suk K Suppressive effects of flavonoid fisetin on lipopolysaccharide-induced microglial activation and neurotoxicity Int Immunopharmacol 2008, 8:484-494. 10.1016/j.intimp.2007.12.012 18279803
221. Kim JS Jobin C The flavonoid luteolin prevents lipopolysaccharide-induced NF-kappaB signalling and gene expression by blocking IkappaB kinase activity in intestinal epithelial cells and bone-marrow derived dendritic cells Immunology 2005, 115:375-387. 1782165 15946255 10.1111/j.1365-2567.2005.02156.x
222. Goyarzu P Malin DH Lau FC Taglialatela G Moon WD Jennings R Moy E Moy D Lippold S Shukitt-Hale B Joseph JA Blueberry supplemented diet: Effects on object recognition memory and nuclear factor-kappa B levels in aged rats Nutr Neurosci 2004, 7:75-83. 10.1080/10284150410001710410 15279493
223. Joseph JA Denisova NA Arendash G Gordon M Diamond D Shukitt-Hale B Morgan D Blueberry supplementation enhances signaling and prevents behavioral deficits in an alzheimer disease model Nutr Neurosci 2003, 6:153-162. 10.1080/1028415031000111282 12793519
224. Obregon DF Rezai-Zadeh K Bai Y Sun N Hou H Ehrhart J Zeng J Mori T Arendash GW Shytle D Town T Tan J ADAM10 activation is required for green tea (-)-epigallocatechin-3-gallate-induced alpha-secretase cleavage of amyloid precursor protein J Biol Chem 2006, 281:16419-16427. 10.1074/jbc.M600617200 16624814
225. Joseph JA Shukitt-Hale B Denisova NA Bielinski D Martin A McEwen JJ Bickford PC Reversals of age-related declines in neuronal signal transduction, cognitive, and motor behavioral deficits with blueberry, spinach, or strawberry dietary supplementation J Neurosci 1999, 19:8114-8121. 10479711
226. Laurin D Masaki KH Foley DJ White LR Launer LJ Midlife dietary intake of antioxidants and risk of late-life incident dementia: The honolulu-asia aging study Am J Epidemiol 2004, 159:959-967. 10.1093/aje/kwh124 15128608
227. White LR Petrovitch H Ross GW Masaki K Hardman J Nelson J Davis D Markesbery W Brain aging and midlife tofu consumption J Am Coll Nutr 2000, 19:242-255. 10763906
228. Engelhart MJ Geerlings MI Ruitenberg A van Swieten JC Hofman A Witteman JC Breteler MM Dietary intake of antioxidants and risk of alzheimer disease JAMA 2002, 287:3223-3229. 10.1001/jama.287.24.3223 12076218
229. Commenges D Scotet V Renaud S Jacqmin-Gadda H Barberger-Gateau P Dartigues JF Intake of flavonoids and risk of dementia Eur J Epidemiol 2000, 16:357-363. 10.1023/A:1007614613771 10959944